Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Samsung Bioepis and Epis NexLab Partner with G2GBIO to Develop Long-acting Semaglutide and Novel Drug Delivery Assets

Tuesday, March 17, 2026

Samsung Bioepis and Epis NexLab have expanded their collaboration with GGBIO beyond a standard licensing deal signalling a broader strategic move into longacting drug delivery and metabolic therapies

Zuellig Pharma Acquires Cialis Tadalafil Rights from Lilly in Three Additional Asian Markets

Friday, March 13, 2026

Zuellig Pharma has acquired the rights to Cialis tadalafil from Eli Lilly in three additional Asian markets strengthening its pharmaceutical distribution portfolio in the region

Johnson & Johnson Receives Approval for TECNIS PureSee Intraocular Lens for Cataract Surgery

Friday, March 13, 2026

Johnson Johnson has received approval from the US Food and Drug Administration FDA for the TECNIS PureSee intraocular lens IOL an extended depth of focus EDOF lens designed for use in cataract surgery

9th Annual Pharma Regulatory Summit 2026 Announces Key Agenda for Asian Pharma Leaders in Mumbai

Thursday, March 12, 2026

The th Annual Pharma Regulatory Summit in Mumbai India set for March will gather Asian pharma executives to discuss regulatory strategies and compliance in the evolving life sciences landscape

Catalent Enters into Partnership with GelMEDIX to Develop iPSC-Derived Cell Therapies for Ocular and Retinal Diseases

Thursday, March 12, 2026

GelMEDIX has entered into a global partnership with Catalent to support the development and clinical manufacturing of induced pluripotent stem cell iPSCderived cell therapies for ocular and retinal diseases

China Implements New Regulations to Accelerate Biotech Drug Approvals and Enhance Market Access

Wednesday, March 11, 2026

The Chinese government has launched new regulations to expedite the approval process for biotech drugs fostering innovation and improving market access for pharmaceutical companies

CSL Seqirus Enters into Agreement with PAHO to Strengthen Influenza Protection

Wednesday, March 11, 2026

CSL Seqirus has entered into a longterm agreement with the Pan American Health Organization PAHO Regional Revolving Fund to support influenza prevention efforts across the Latin American region

Samsung Biologics Enters into Collaboration with Eli Lilly to Establish Gateway Labs Facility

Wednesday, March 11, 2026

Samsung Biologics has announced a collaboration with Eli Lilly and Company to establish a new Lilly Gateway Labs facility in South Korea The new Gateway Labs site will function as a hub designed to support earlystage and emerging biotechnology compan...

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Global Platform

Monday, March 09, 2026

Royalty Pharma has appointed Kenneth Sun as SVP and Head of Asia based in Hong Kong to lead expansion into the regions booming biopharma royalty market

Chinese Pharma Outlicensing Hits Record Pace in Early 2026 Amid Asia's Biopharma Surge

Friday, March 06, 2026

Chinese drug developers are setting records with billiondollar outlicensing agreements to international partners signaling Chinas rise as a key source of innovative drug candidates for global pharma firms